SEC 13F Intelligence

Manning & Napier Group, LLC / BSX

Manning & Napier Group, LLC’s Boston Scientific Corp Position

Does Manning & Napier Group, LLC own Boston Scientific Corp (BSX)? Yes258.1K shares worth $18M (+0.20% of its 13F portfolio) as of Q1 2024, down from 299.6K shares the prior filed quarter.

Position Value
$18M
Q1 2024
Shares
258.1K
% of Portfolio
+0.20%
Quarters Held
20
currently held

Position History BSX

Reported value by quarter
Q2 ’19: $26MQ2 ’19Q3 ’19: $22MQ4 ’19: $22MQ1 ’20: $12MQ1 ’20Q2 ’20: $14MQ3 ’20: $15MQ4 ’20: $15MQ4 ’20Q1 ’21: $18MQ2 ’21: $19MQ3 ’21: $19MQ3 ’21Q4 ’21: $19MQ1 ’22: $19MQ2 ’22: $15MQ2 ’22Q3 ’22: $16MQ4 ’22: $17MQ1 ’23: $23MQ1 ’23Q2 ’23: $25MQ3 ’23: $16MQ4 ’23: $17MQ4 ’23Q1 ’24: $18Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024258.1K$18M+0.20%
Q4 2023299.6K$17M+0.21%
Q3 2023300.9K$16M+0.20%
Q2 2023462.9K$25M+0.29%
Q1 2023468.2K$23M+0.27%
Q4 2022366.2K$17M+0.21%
Q3 2022405.8K$16M+0.21%
Q2 2022406.4K$15M+0.17%
Q1 2022431.6K$19M+0.18%
Q4 2021443.6K$19M+0.16%
Q3 2021444.5K$19M+0.17%
Q2 2021446.7K$19M+0.16%
Q1 2021460.6K$18M+0.15%
Q4 2020428.7K$15M+0.14%
Q3 2020383.9K$15M+0.15%
Q2 2020389.5K$14M+0.15%
Q1 2020374.2K$12M+0.14%
Q4 2019495.4K$22M+0.24%
Q3 2019535.5K$22M+0.24%
Q2 2019605.9K$26M+0.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Manning & Napier Group, LLC’s full portfolio or all institutional holders of BSX.